Report for State Insurance Commissioners Offers Options to Improve Drug Access
- Podcast: ‘What The Health?’ The State Of The (Health) Union
- As Marijuana Laws Relax, Doctors Say Pregnant Women Shouldn’t Partake
- Expert Advice For The Corporate Titans Taking On Health Care
- After Polyps Are Detected, Patients May No Longer Qualify For Free Colonoscopies
- No Car, No Care? Medicaid Transportation At Risk In Some States
As prescription drug costs continue to rise, ensuring that consumers have access to the drugs they need is a growing concern. Insurers blame the drug companies for high prices while drug companies blame insurers for restrictive plans. Consumers are stuck in the middle picking up a higher tab. Now a new study highlights strategies for states to help consumers in this tug of war.
The report, by a group of patient and consumer advocates who are representatives to the National Association of Insurance Commissioners (NAIC), is being released today and will be presented this weekend at the summer meeting of the NAIC.
“States are moving ahead,” said Katie Keith, an attorney who works with the NAIC consumer representatives and helped write the report. “There are best practices out there and states are making changes.”
The report describes steps states can take to address a number of drug-coverage issues in the commercial insurance market, including:
- Limiting the number of cost-sharing tiers that insurers can use in a plan. Standardized plans in Massachusetts, New York and Vermont that are offered on the health law’s insurance marketplace are limited to three tiers.
- Limiting consumer out-of-pocket spending by, for instance, prohibiting plans from charging coinsurance, which is a percentage of the cost of a drug, instead of using flat dollar copayments. In Montana, for example, insurers have to offer at least one marketplace plan at the silver level or higher that charges only copayments in all drug tiers.
- Prohibiting plans from changing their formulary, or list of covered drugs, midway through the year. Texas and Nevada have prohibited most formulary changes, while other states have limited changes and some required insurers to notify consumers when changes are made.
The scope of the strategies vary. Some apply to the individual and small group markets only, others affect large group plans that are fully insured.
“States have long played this role, trying to make policies that work for consumers,” said Keith.
“It’s more urgent now with all the crazy drug prices we’re seeing.”
The NAIC develops model laws and regulations on various subjects that states can use as templates for their own rule-making. This report is intended to inform NAIC members as they move to revise the existing model law, the Health Carrier Prescription Drug Benefit Management Model Act, which was last updated in 2003, Keith said.
This story was updated to clarify Katie Keith’s work with NAIC.
Please contact Kaiser Health News to send comments or ideas for future topics for the Insuring Your Health column.